Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects

Toxicology and Applied Pharmacology

Volumn 272, Issue 1, 2013, Pages 154-160

  Takahashi, Kei ^a   Yokota, Shin ichi ^a   Tatsumi, Naoyuki ^a   Fukami, Tatsuki ^a   Yokoi, Tsuyoshi ^a   Nakajima, Miki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Biomarker; MicroRNA; Smoking

Indexed keywords

BIOLOGICAL MARKER; CIGARETTE SMOKE; MICRORNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; SMOKING;

BIOMARKER; MICRORNA; SMOKING;

ADULT; BIOLOGICAL MARKERS; COTININE; HUMANS; INDICATORS AND REAGENTS; MALE; MICRORNAS; MIDDLE AGED; NICOTINE; PRINCIPAL COMPONENT ANALYSIS; SMOKING; SMOKING CESSATION; YOUNG ADULT;

EID: 84882769605     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.05.018     Document Type: Article

References (68)

1. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001, 107:823-826.
2. Bloomer R.J. Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: impact of dietary intake. Nutr. J. 2007, 6:39.
3. Bryant R.J., Pawlowski T., Catto J.W., Marsden G., Vessella R.L., Rhees B., Kuslich C., Visakorpi T., Hamdy F.C. Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 2012, 106:768-774.
4. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
5. Cookson V.J., Bentley M.A., Hogan B.V., Horgan K., Hayward B.E., Hazelwood L.D., Hughes T.A. Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours. Cell. Oncol. 2012, 35:301-308.
6. Crosby M.E., Devlin C.M., Glazer P.M., Calin G.A., Ivan M. Emerging roles of microRNAs in the molecular responses to hypoxia. Curr. Pharm. Des. 2009, 15:3861-3866.
7. De Flora S., Camoirano A., Bagnasco M., Bennicelli C., van Zandwijk N., Wigbout G., Qian G.S., Zhu Y.R., Kensler T.W. Smokers and urinary genotoxins: implications for selection of cohorts and modulation of endpoints in chemoprevention trials. J. Cell. Biochem. 1996, 25S:92-98.
8. De Flora S., Balansky R., D'Agostini F., Cartiglia C., Longobardi M., Steele V.E., Izzotti A. Smoke-induced microRNA and related proteome alterations. Modulation by chemopreventive agents. Int. J. Cancer 2012, 131:2763-2773.
9. Duttagupta R., Jiang R., Gollub J., Getts R.C., Jones K.W. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 2011, 6:e20769.
10. Fu Y., Yi Z., Wu X., Li J., Xu F. Circulating microRNAs in patients with active pulmonary tuberculosis. J. Clin. Microbiol. 2011, 49:4246-4251.
11. Graff J.W., Powers L.S., Dickson A.M., Kim J., Reisetter A.C., Hassan I.H., Kremens K., Gross T.J., Wilson M.E., Monick M.M. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One 2012, 7:e44066.
12. Hanke M., Hoefig K., Merz H., Feller A.C., Kausch I., Jocham D., Warnecke J.M., Sczakiel G. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 2010, 28:655-661.
13. He L., Hannon G.L. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
14. Heneghan H.M., Miller N., Kelly R., Newell J., Kerin M.J. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 2010, 15:673-682.
15. Higgins M.W., Keller J.B., Landis J.R., Beaty T.H., Burrows B., Demets D., Diem J.E., Higgins I.T., Lakatos E., Lebowitz M.D. Risk of chronic obstructive pulmonary disease. Collaborative assessment of the validity of the Tecumseh index of risk. Am. Rev. Respir. Dis. 1984, 130:380-385.
16. Hoffmann D., Hoffmann I., El-Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 2001, 14:767-790.
17. Holbrook J.H., Grundy S.M., Hennekens C.H., Kannel W.B., Strong J.P. Cigarette smoking and cardiovascular diseases. A statement for health professionals by a task force appointed by the steering committee of the American Heart Association. Circulation 1984, 70:1114A-1117A.
18. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 127:118-126.
19. Izzotti A., Calin G.A., Arrigo P., Steele V.E., Croce C.M., De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009, 23:806-812.
20. Izzotti A., Calin G.A., Steele V.E., Croce C.M., De Flora S. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 2009, 23:3243-3250.
21. Izzotti A., Larghero P., Longobardi M., Cartiglia C., Camoirano A., Steele V.E., De Flora S. Dose-responsiveness and persistence of microRNA expression alterations induced by cigarette smoke in mouse lung. Mutat. Res. 2011, 717:9-16.
22. Ji J., Shi J., Budhu A., Yu Z., Forgues M., Roessler S., Ambs S., Chen Y., Meltzer P.S., Croce C.M., Qin L.X., Man K. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 2009, 361:1437-1447.
23. Kanemaru H., Fukushima S., Yamashita J., Honda N., Oyama R., Kakimoto A., Masuguchi S., Ishihara T., Inoue Y., Jinnin M., Ihn H. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J. Dermatol. Sci. 2011, 61:187-193.
24. Komatsu S., Ichikawa D., Takeshita H., Tsujiura M., Morimura R., Nagata H., Kosuga T., Iitaka D., Konishi H., Shiozaki A., Fujiwara H., Okamoto K., Otsuji E. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 2011, 105:104-111.
25. Lee Y., El Andaloussi S., Wood M.J. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum. Mol. Genet. 2012, 21:R125-R134.
26. Li B.S., Zhao Y.L., Guo G., Li W., Zhu E.D., Luo X., Mao X.H., Zou Q.M., Yu P.W., Zuo Q.F., Li N., Tang B., Liu K.Y., Xiao B. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 2010, 7:e41629.
27. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166.
28. Long G., Wang F., Duan Q., Chen F., Yang S., Gong W., Wang Y., Chen C., Wang D.W. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int. J. Biol. Sci. 2012, 8:811-818.
29. Long G., Wang F., Duan Q., Yang S., Chen F., Gong W., Yang X., Wang Y., Chen C., Wang D.W. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One 2012, 7:e50926.
30. Maccani M.A., Avissar-Whiting M., Banister C.E., McGonnigal B., Padbury J.F., Marsit C.J. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics 2010, 5:583-589.
31. Mahn R., Heukamp L.C., Rogenhofer S., von Ruecker A., Müller S.C., Ellinger J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011, 77:1265.e9-1265.e16.
32. Meder B., Keller A., Vogel B., Haas J., Sedaghat-Hamedani F., Kayvanpour E., Just S., Borries A., Rudloff J., Leidinger P., Meese E., Katus H.A., Rottbauer W. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res. Cardiol. 2011, 106:13-23.
33. Meltzer P.S. Cancer genomics: small RNAs with big impacts. Nature 2005, 435:745-746.
34. Michael A., Bajracharya S.D., Yuen P.S., Zhou H., Star R.A., Illei G.G., Alevizos I. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2010, 16:34-38.
35. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10513-10518.
36. Nakajima M., Yamamoto T., Kuroiwa Y., Yokoi T. Improved highly sensitive method for determination of nicotine and cotinine in human plasma by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 2000, 742:211-215.
37. Nielsen L.B., Wang C., Sørensen K., Bang-Berthelsen C.H., Hansen L., Andersen M.L., Hougaard P., Juul A., Zhang C.Y., Pociot F., Mortensen H.B. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual β-cell function and glycaemic control during disease progression. Exp. Diabetes Res 2013, (2012, Article ID 896362).
38. Olivieri F., Antonicelli R., Lorenzi M., D'Alessandra Y., Lazzarini R., Santini G., Spazzafumo L., Lisa R., La Sala L., Galeazzi R., Recchioni R., Testa R., Pompilio G., Capogrossi M.C., Procopio A.D. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int. J. Cardiol 2013, (in press). 10.1016/j.ijcard.2012.11.103.
39. Park N.J., Zhou H., Elashoff D., Henson B.S., Kastratovic D.A., Abemayor E., Wong D.T. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 2009, 15:5473-5477.
40. Pu X.X., Huang G.L., Guo H.Q., Guo C.C., Li H., Ye S., Ling S., Jiang L., Tian Y., Lin T.Y. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J. Gastroenterol. Hepatol. 2010, 25:1674-1680.
41. Qi P., Cheng S.Q., Wang H., Li N., Chen Y.F., Gao C.F. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011, 6:e28486.
42. Qu K.Z., Zhang K., Li H., Afdhal N.H., Albitar M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J. Clin. Gastroenterol. 2011, 45:355-360.
43. Redova M., Poprach A., Nekvindova J., Iliev R., Radova L., Lakomy R., Svoboda M., Vyzula R., Slaby O. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J. Transl. Med. 2012, 10:55.
44. Reid G., Kirschner M.B., van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit. Rev. Oncol. Hematol. 2011, 80:193-208.
45. Schembri F., Sridhar S., Perdomo C., Gustafson A.M., Zhang X., Ergun A., Lu J., Liu G., Zhang X., Bowers J., Vaziri C., Ott K., Sensinger K., Collins J.J., Brody J.S., Getts R., Lenburg M.E., Spira A. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2319-2324.
46. Shende V.R., Goldrick M.M., Ramani S., Earnest D.J. Expression and rhythmic modulation of circulating microRNAs targeting the clock gene Bmal1 in mice. PLoS One 2011, 6:e22586.
47. Shields P.G. Molecular epidemiology of lung cancer. Ann. Oncol. 1999, 5:S7-S11.
48. Si H., Sun X., Chen Y., Cao Y., Chen S., Wang H., Hu C. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J. Cancer Res. Clin. Oncol 2013, 139:223-229.
49. Silva J., García V., Zaballos Á., Provencio M., Lombardía L., Almonacid L., García J.M., Domínguez G., Peña C., Diaz R., Herrera M., Varela A., Bonilla F. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur. Respir. J. 2011, 37:617-623.
50. Tsujiura M., Ichikawa D., Komatsu S., Shiozaki A., Takeshita H., Kosuga T., Konishi H., Morimura R., Deguchi K., Fujiwara H., Okamoto K., Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 2010, 102:1174-1179.
51. Ulrik C.S., Lange P. Cigarette smoking and asthma. Monaldi Arch. Chest Dis. 2001, 56:349-353.
52. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 2011, 13:423-433.
53. Villar A.V., García R., Merino D., Llano M., Cobo M., Montalvo C., Martín-Durán R., Hurlé M.A., Nistal J.F. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int. J. Cardiol 2013, (in press). 10.1016/j.ijcard.2012.07.021.
54. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4402-4407.
55. Wang J.F., Yu M.L., Yu G., Bian J.J., Deng X.M., Wan X.J., Zhu K.M. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun. 2010, 394:184-188.
56. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010, 38:7248-7259.
57. Wang R., Li N., Zhang Y., Ran Y., Pu J. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern. Med. 2011, 50:1789-1795.
58. Wang H., Peng W., Ouyang X., Li W., Dai Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 2012, 160:198-206.
59. Wang K., Yuan Y., Cho J.H., McClarty S., Baxter D., Galas D.J. Comparing the microRNA spectrum between serum and plasma. PLoS One 2012, 7:e41561.
60. Wei J., Gao W., Zhu C.J., Liu Y.Q., Mei Z., Cheng T., Shu Y.Q. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin. J. Cancer 2011, 30:407-414.
61. Xu J., Wu C., Che X., Wang L., Yu D., Zhang T., Huang L., Li H., Tan W., Wang C., Lin D. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol. Carcinog. 2011, 50:136-142.
62. Yamaguchi Y., Haginaka J., Morimoto S., Fujijoka Y., Kunimoto M. Facilitated nitration and oxidation of LDL in cigarette smokers. Eur. J. Clin. Invest. 2005, 35:186-193.
63. Yamanaka H., Nakajima M., Nishimura K., Yoshida R., Fukami T., Katoh M., Yokoi T. Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted. Eur. J. Pharm. Sci. 2004, 22:419-425.
64. Yamaura Y., Nakajima M., Takagi S., Fukami T., Tsuneyama K., Yokoi T. Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PLoS One 2012, 7:e30250.
65. Yu S., Liu Y., Wang J., Guo Z., Zhang Q., Yu F., Zhang Y., Huang K., Li Y., Song E., Zheng X.L., Xiao H. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 2012, 97:2084-2092.
66. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107:810-817.
67. Zeng X., Xiang J., Wu M., Xiong W., Tang H., Deng M., Li X., Liao Q., Su B., Luo Z., Zhou Y., Zhou M., Zeng Z., Li X., Shen S., Shuai C., Li G., Fang J., Peng S. Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One 2012, 7:e46367.
68. Zheng Y., Cui L., Sun W., Zhou H., Yuan X., Huo M., Chen J., Lou Y., Guo J. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark. 2011-2012, 10:71-77.